Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Intraocular Lymphoma × ibrutinib × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 49 Lymphoma, Mantle-Cell 30 Lymphoma, Follicular 17 Lymphoma, Large B-Cell, Diffuse 14 Lymphoma 13 Waldenstrom Macroglobulinemia 11 Lymphoma, Non-Hodgkin 11 Lymphoma, B-Cell 11 Recurrence 8 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Lymphoid 5 Leukemia, B-Cell 5 Leukemia 5 Multiple Myeloma 4 Bronchiolitis Obliterans Syndrome 4 Hodgkin Disease 3 Hematologic Neoplasms 3 Burkitt Lymphoma 3 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Graft vs Host Disease 2 Chromosome 17 deletion 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1

Interventions

Cyclophosphamide 9 fludarabine phosphate 8 Whole-Body Irradiation 8 Rituximab 8 Cyclosporine 8 Peripheral Blood Stem Cell Transplantation 7 Filgrastim 7 Mycophenolic Acid 6 Dexamethasone 5 Methotrexate 4 Etoposide 4 Vorinostat 3 Tacrolimus 3 Radiotherapy 3 Lenalidomide 3 Irinotecan 3 Cytarabine 3 Carboplatin 3 Busulfan 3 Bortezomib 3 laromustine 2 entinostat 2 Thiotepa 2 Therapeutics 2 Prednisone 2 Paclitaxel 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2 Flow Cytometry 2 Enzyme-Linked Immunosorbent Assay 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02542514 2022-04-14

iLOC

The Lymphoma Academic Research Organisation

Phase 2 Completed

Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡